Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes! That s HUGE! Massive news out for ONPH who are in partnership with $RGBP. Can this mean RGBP will soon apply to become Nasdaq as well? Going to keep buying all the dips I can of $RGBP
https://finance.yahoo.com/news/oncology-pharma-inc-submitted-initial-021000662.html
Maybe... Is Regen BioPharma A Buyout Target? Potential (OTCQB:RGBP)
Summary
Buyout Target Potential (Bristol Myers-IMF Therapeutics $2.3B)
N2RF6 10X Less Toxic-Most Advanced in industry
VariousCancers, Lupus, Rare Blood & Auto Immune Disease Treatments
Bio Tech-Stem Cell Clinical Stage Company
https://seekingalpha.com/instablog/32618395-small-cap-solutions-llc/5024702-is-regen-biopharma-buyout-target-potential-otcqb-rgbp
Love that sexy chart!
$RGBP Get your GOLDEN ticket and locked away for while and you will be happier later
Oh, we all been there as JANEm PAUL BEEN TRYING TO STEAL OUR SHARES but haven't sold a single share! however, I was GLAD to accumulate more shares! This is a rare opportunity to grab the hottest OTC stock in a while! I know what I own $RGBP!
You just describe mRNA N NR2F6 in very simple logics onto thousand words to defeat cancer! Cancer vaccine? Wow!
We all suspected that will happen! Follow the money!
$RGBP $$$ machine! Follow the money!
There you go! $RGBP $$$ machine! Follow the money!
YUP! LOAD AND LOCK! $RGBP $$$ machine! Follow the money!
$RGBP $$$ machine! Follow the money!
That's really YUGE!
Amazing! Koo wants to get RGBP to current!
Killer news! It keeps coming!
Gene silencing is an amazing technology! The experiments revealed that administration of Regen's proprietary gene silencing compounds triggered cells of the immune system to profoundly produce growth factors such as interleukin-17 and interleukin-18. These factors are critical to inducing an anticancer immune response. The company is currently developing a cellular product that involves extraction of a small amount of patient blood, isolating specific immune cells from the blood, gene-silencing the NR2F6 target in the extracted immune cells, and subsequently re-administering the immune cells. The goal is to "reprogram" the immune cells to attack tumors.
That's YUGE for us! Many more things are coming for us!
You're welcome! Yes! Big institutional will buy once RGBP is current! Best GEM out there!
Skiluc and others who have put the endless hours and efforts in here! Want to thank you all! Lets go $RGBP...
Agreed Go enjoy riding ATVK! No hurry to sell $RGBP!